Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT01006902
Eligibility Criteria:
Inclusion Criteria:
* Age 65 or older
* Diagnosis of a malignancy requiring chemotherapy as part of intent to cure oncologic therapy or diagnosis of prostate cancer requiring 6 months or less of androgen deprivation therapy as part of oncologic treatment.
* A planned oncologic regimen of at least 3 months but not more than 9 months excluding surgery. This will include most solid tumors and lymphoma.
* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
* Prior treatment for malignancy other than basal or squamous cell skin cancer
* Evidence of metastatic disease
* Individuals with acute and chronic leukemias and individuals receiving anti-estrogen therapy only as their primary oncologic treatment.
* Dementia, psychotic condition or other central nervous system impairment limiting compliance
* Medical conditions that limit ability to walk at least 4 meters.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
90 Years
Study:
NCT01006902
Study Brief:
Protocol Section:
NCT01006902